Source: Annual Congress 2005 - Biological and treatment aspects of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. R. Bloorsaz, S. Khalilzadeh (Tehran, Islamic Republic Of Iran). Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 2907

Member's Comments

No comment yet.

Related content which might interest you: Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008 Evaluating the nutritional status in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 427s Year: 2005 Changes in the metabolism of Mycobacterium tuberculosis during the course of TB treatment Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Effect on treatment of giving information about tuberculosis to the tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 644s Year: 2005 Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004 Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients Source: Eur Respir J 2014; 44: 1373-1375 Year: 2014 Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Impact of mono- and poli-resistance on the treatment outcomes of pulmonary tuberculosis Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Rimfampicin importance in tuberculosis treatment Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Monitoring during and after tuberculosis treatment Source: Eur Respir Monogr 2018; 82: 308-325 Year: 2018 Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Antituberculosis drug-induced hepatotoxicity: influence on the management and outcome of active tuberculosis (TB) Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007 Diagnosing and treatment of latent tuberculosis infction in children Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Does anti TNF-α treatment increase tuberculosis risk? Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007